Head-To-Head Comparison: Doximity (DOCS) versus Its Competitors

Doximity (NYSE:DOCS) is one of 48 publicly-traded companies in the “Services – Computer Programming And Data Processing” industry, but how does it compare to its rivals? We will compare Doximity to similar companies based on the strength of its risk, dividends, analyst recommendations, earnings, profitability, institutional ownership and valuation.

Profitability

This table compares Doximity and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Doximity	40.72%	24.63%	21.30%
Doximity Competitors	-51.08%	-912.69%	-63.05%

Analyst Ratings

This is a summary of current recommendations and price targets for Doximity and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	0	2	2	3	3.14
Doximity Competitors	100	197	218	12	2.27

Doximity currently has a consensus price target of $55.00, suggesting a potential upside of 64.67%. As a group, “Services – Computer Programming And Data Processing” companies have a potential upside of 146.72%. Given Doximity’s rivals higher possible upside, analysts plainly believe Doximity has less favorable growth aspects than its rivals.

Volatility & Risk

Doximity has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Doximity’s rivals have a beta of 0.68, meaning that their average stock price is 32% less volatile than the S&P 500.

Institutional & Insider Ownership

87.2% of Doximity shares are owned by institutional investors. Comparatively, 57.5% of shares of all “Services – Computer Programming And Data Processing” companies are owned by institutional investors. 31.3% of Doximity shares are owned by insiders. Comparatively, 20.5% of shares of all “Services – Computer Programming And Data Processing” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Doximity and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Doximity	$570.40 million	$223.18 million	26.51
Doximity Competitors	$255.93 million	-$53.25 million	-11.65

Doximity has higher revenue and earnings than its rivals. Doximity is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Doximity beats its rivals on 11 of the 13 factors compared.

Doximity Company Profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.